Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation
DA Marshall, KV MacDonald, D Kao… - … in Chronic Disease, 2024 - journals.sagepub.com
Background: Fecal microbiota transplantation (FMT) is a promising treatment for active
ulcerative colitis (UC). Understanding patient preferences can identify treatment features that …
ulcerative colitis (UC). Understanding patient preferences can identify treatment features that …
[HTML][HTML] Patient preferences for advanced therapies in ulcerative colitis using conjoint analysis
T Kobayashi, N Mizuno, N Sato, Y Kawaguchi… - Intestinal …, 2024 - irjournal.org
Background/Aims Selecting an optimal advanced therapy for ulcerative colitis (UC) is difficult
because of the increasing number of available therapies. This study assessed UC patients' …
because of the increasing number of available therapies. This study assessed UC patients' …
Patient and Healthcare Professional Satisfaction, Acceptability, and Preference Experiences With Mirikizumab Administration for Ulcerative Colitis: An International …
D Clemow, C Radawski, J Milata, K Alaka… - Crohn's & Colitis …, 2024 - academic.oup.com
Background There is a need to better understand ulcerative colitis (UC) patient and
healthcare provider (HCP) treatment satisfaction, acceptability, and preferences. Methods …
healthcare provider (HCP) treatment satisfaction, acceptability, and preferences. Methods …
[PDF][PDF] Patient and Healthcare Professional Satisfaction, Acceptability, and Preference Experiences with Mirikizumab Administration for Ulcerative Colitis: an …
TH Gibble, A Schaum, O Ezennia, N Martinez - 2024 - szalokitibor.hu
Accepted Manuscript Page 1 Accepted Manuscript © The Author(s) 2024. Published by Oxford
University Press on behalf of Crohn's & Colitis Foundation. This is an Open Access article …
University Press on behalf of Crohn's & Colitis Foundation. This is an Open Access article …